MARCATOR
MARCATOR
Multicenter American Research trial with Cilazapril after Angioplasty to prevent Transluminal coronary Obstruction and Restenosis. A clinical trial that evaluated ACE inhibition for preventing restenosis after PCTA in patients with CAD.Conclusion
Long-term ACE inhibition by cilazapril neither prevented restenosis nor reduced post-PCTA cardiac events.